CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Pietroboni AM, Schiano di Cola F, Scarioni M, Fenoglio C, Spanò B, Arighi A, Cioffi SMG, Oldoni E, De Riz MA, Basilico P, et al. Mult Scler. 2016 Oct 17. PMID: 27754941. Abstract CommentRecommendBookmarkWatch